No Data
US Stock MarketDetailed Quotes
FBIO Fortress Biotech
Watchlist
2.6500
-0.0200-0.75% Trading 12/06 12:56 ET
2.7900High2.5200Low262.37KVolume
2.6900Open2.6700Pre Close697.77KTurnover2.50%Turnover RatioLossP/E (TTM)39.29MMarket Cap17.400052wk HighLossP/E (Static)14.83MShares1.240052wk Low2.36P/B27.84MFloat Cap190.5000Historical High--Dividend TTM10.51MShs Float1.2400Historical Low--Div YieldTTM10.11%Amplitude2.6590Avg Price1Lot Size
Intraday
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About Fortress Biotech Company
Fortress Biotech, Inc. engages in the manufacture and commercialization of novel pharmaceutical products and product candidates. It operates through the Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development segments. Its products include Ximino, Targadox, Exelderm, Ceracade, and Luxamend. The company was founded in 2006 and is headquartered in Bay Harbor Islands, FL.
Revenue Breakdown
Business
Currency:USD
2022/12/31
Stock NameRevenueRatio
Dermatology Products Sales73.67M97.26%
Pharmaceutical and Biotechnology Product Development2.07M2.74%
News
Express News | Cyprium Received $4.5M Payment On Closing And Remains Eligible To Receive Royalties And Up To $129M In Aggregate Development And Sales Milestones; Retains 100% Ownership Over Any FDA Priority Review Voucher That May Be Issued At NDA Approval For CUTX-101
Checkpoint Therapeutics Strengthens Intellectual Property Protection for Cosibelimab With New U.S. Patent Issuance
Upcoming PDUFA goal date of January 3, 2024 U.S. patent protection for cosibelimab through at least May 2038 WALTHAM, Mass., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. ("Checkpoint")
Roth MKM Maintains Buy on Fortress Biotech, Lowers Price Target to $15
Roth MKM analyst Scott Henry maintains Fortress Biotech (NASDAQ:FBIO) with a Buy and lowers the price target from $30 to $15.
Comments
$Fortress Biotech(FBIO.US$
The information provided is related to Fortress Biotech Inc Series A P (FBIOP.US) and its upcoming ex-dividend date on November 14th, 2023. Shareholders of record on November 15th, 2023, will receive a cash dividend of 0.19531 USD per share on November 30th, 2023.
The article also provides a brief explanation of cash dividends and stock dividends. Cash dividends involve the distribution of cash to shareholders, but they can have tax consequences and may impact the ...
The information provided is related to Fortress Biotech Inc Series A P (FBIOP.US) and its upcoming ex-dividend date on November 14th, 2023. Shareholders of record on November 15th, 2023, will receive a cash dividend of 0.19531 USD per share on November 30th, 2023.
The article also provides a brief explanation of cash dividends and stock dividends. Cash dividends involve the distribution of cash to shareholders, but they can have tax consequences and may impact the ...
1
$Fortress Biotech(FBIO.US$
The information you've provided appears to be related to a securities offering by Fortress Biotech, Inc. The company is offering units that consist of common stock and warrants, as well as pre-funded units with similar components. Here are some key points:
1. **Securities Offered**: The offering includes units, each containing one share of common stock and one warrant to purchase one share of common stock. There are also pre-funded units available for certain purchas...
The information you've provided appears to be related to a securities offering by Fortress Biotech, Inc. The company is offering units that consist of common stock and warrants, as well as pre-funded units with similar components. Here are some key points:
1. **Securities Offered**: The offering includes units, each containing one share of common stock and one warrant to purchase one share of common stock. There are also pre-funded units available for certain purchas...
Read more
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--